Cargando…

A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy

BACKGROUND: Some clinical researchers have reported that patients with cCR (clinical complete response) status after neoadjuvant chemoradiotherapy (nCRT) could adopt the watch-and-wait (W&W) strategy. Compared with total mesorectal excision (TME) surgery, the W&W strategy could achieve a sim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Guilin, Lu, Wenqing, Jiao, Zhouguang, Qiao, Jun, Ma, Shiyang, Liu, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522111/ https://www.ncbi.nlm.nih.gov/pubmed/34663341 http://dx.doi.org/10.1186/s12957-021-02415-y

Ejemplares similares

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
por: He, Fang, et al.
Publicado: (2022)

The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy
por: Wang, Qiao-xuan, et al.
Publicado: (2021)

Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers
por: Lim, Yon Kuei, et al.
Publicado: (2010)

Selected stage IV rectal cancer patients managed by the watch‐and‐wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?
por: Custers, Petra A., et al.
Publicado: (2022)

Total mesorectal excision for the treatment of rectal cancer
por: Zedan, Ali, et al.
Publicado: (2015)

Robotic total mesorectal excision for the treatment of rectal cancer
por: Baik, Seung Hyuk, et al.
Publicado: (2007)

Update on Robotic Total Mesorectal Excision for Rectal Cancer
por: Giuratrabocchetta, Simona, et al.
Publicado: (2021)

Local Excision ± Chemoradiotherapy vs. Total Mesorectal Excision for Early Rectal Cancer: Case-Matched Analysis of Long-Term Results
por: Pacevicius, Julius, et al.
Publicado: (2021)

Combination of Changes in CEA and CA199 Concentration After Neoadjuvant Chemoradiotherapy Could Predict the Prognosis of Stage II/III Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision
por: Zhao, Jieyi, et al.
Publicado: (2022)

Urinary dysfunction in women following total mesorectal excision versus partial mesorectal excision for treatment of rectal cancer
por: Chill, Henry H., et al.
Publicado: (2021)

Rectal Sparing Approaches after Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-Analysis Comparing Local Excision and Watch and Wait
por: Bao, Quoc Riccardo, et al.
Publicado: (2023)

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy
por: Solanki, Abhishek A, et al.
Publicado: (2013)

Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)
por: Temmink, Sofieke J D, et al.
Publicado: (2023)

Voiding Dysfunction after Total Mesorectal Excision in Rectal Cancer
por: Kim, Jae Heon, et al.
Publicado: (2011)

Prognosis comparison between wait and watch and surgical strategy on rectal cancer patients after treatment with neoadjuvant chemoradiotherapy: a meta-analysis
por: Pang, Kai, et al.
Publicado: (2019)

The watch-and-wait strategy versus radical resection for rectal cancer patients with a good response (≤ycT2) after neoadjuvant chemoradiotherapy
por: Lee, Chungyeop, et al.
Publicado: (2022)

Role of Local Excision for Suspected Regrowth in a Watch and Wait Strategy for Rectal Cancer
por: Geubels, Barbara M., et al.
Publicado: (2022)

Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation
por: Cui, Christina Liu, et al.
Publicado: (2021)

Watch and Wait Approach for Rectal Cancer
por: Cerdan-Santacruz, Carlos, et al.
Publicado: (2023)

Impact of Body Mass Index on Surgical and Oncological Outcomes in Laparoscopic Total Mesorectal Excision for Locally Advanced Rectal Cancer after Neoadjuvant 5-Fluorouracil-Based Chemoradiotherapy
por: Sun, Yanwu, et al.
Publicado: (2017)

Oncologic Outcomes in Patients Who Undergo Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision for Locally Advanced Rectal Cancer: A 14-Year Experience in a Single Institution
por: Kim, Min Jung, et al.
Publicado: (2019)

Neoadjuvant concurrent chemoradiotherapy followed by transanal total mesorectal excision assisted by single-port laparoscopic surgery for low-lying rectal adenocarcinoma: a single center study
por: Lu, Yen-Jung, et al.
Publicado: (2020)

Pretreatment Albumin-to-Fibrinogen Ratio Independently Predicts Chemotherapy Response and Prognosis in Patients with Locally Advanced Rectal Cancer Undergoing Total Mesorectal Excision After Neoadjuvant Chemoradiotherapy
por: Li, Hongzhi, et al.
Publicado: (2020)

Female urogenital dysfunction following total mesorectal excision for rectal cancer
por: Daniels, Ian R, et al.
Publicado: (2006)

Transumbilical laparoendoscopic single-site total mesorectal excision for rectal carcinoma
por: Michalik, Maciej, et al.
Publicado: (2012)

Transanal Total Mesorectal Excision With Single-Incision Laparoscopy for Rectal Cancer
por: Foo, Dominic Chi-chung, et al.
Publicado: (2016)

Transanal Total Mesorectal Excision for Rectal Cancer: Perioperative and Oncological Outcomes
por: Hur, Hyuk
Publicado: (2018)

From Total Mesorectal Excision to Organ Preservation for the Treatment of Rectal Cancer
por: Baek, Seong Kyu
Publicado: (2019)

Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer
por: Maykel, Justin A., et al.
Publicado: (2022)

Association of Transanal Total Mesorectal Excision With Local Recurrence of Rectal Cancer
por: Caycedo-Marulanda, Antonio, et al.
Publicado: (2021)

Learning Curve of Robotic-Assisted Total Mesorectal Excision for Rectal Cancer
por: Tang, Bo, et al.
Publicado: (2022)

Oncological monitoring after transanal total mesorectal excision for rectal neoplasia
por: Gachabayov, M., et al.
Publicado: (2023)

Oncological outcomes after transanal total mesorectal excision for rectal cancer
por: Francis, Nader K, et al.
Publicado: (2023)

The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study
por: Akgun, Erhan, et al.
Publicado: (2017)

Long-term efficacy of transanal local excision versus total mesorectal excision after neoadjuvant treatment for rectal cancer: A meta-analysis
por: Lei, Yihui, et al.
Publicado: (2023)

Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy
por: Koo, Taeryool, et al.
Publicado: (2015)

Transanal Total Mesorectal Excision (TaTME) versus Laparoscopic Total Mesorectal Excision for Lower Rectal Cancer: A Propensity Score-Matched Analysis
por: Lin, Yueh-Chen, et al.
Publicado: (2022)

A systematic review and meta-analysis of minimally invasive total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer
por: Gang, Du Yong, et al.
Publicado: (2023)

Introduction to Total Mesorectal Excision
por: Delibegovic, Samir
Publicado: (2017)

Clinical feasibility of the therapeutic strategies total neoadjuvant therapy and “watch and wait” in the treatment of rectal cancer patients with recurrence after clinical complete response
por: Dai, Dianyin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fqdunh2n6m4mr7u2nkn75n5l21